tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Eric Criscuolo, 19 are a HOLD (59.38%), 1 are a SELL (3.13%), 12 are a BUY (37.5%).
Analyst Eric Criscuolo, carries an average stock price target met ratio of 93.75% that have a potential upside of 13.64% achieved within 197 days. Previously, Eric Criscuolo worked at MIZUHO.
Eric Criscuolo’s has documented 58 price targets and ratings displayed on 8 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CLVS, Clovis Oncology at 24-Aug-2016.
Analyst best performing recommendations are on EXAS (EXACT SCIENCES).
The best stock recommendation documented was for EXAS (EXACT SCIENCES) at 6/15/2016. The price target of $10 was fulfilled within 1 day with a profit of $0.67 (7.18%) receiving and performance score of 71.81.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$70
$27.45 (64.51%)
$75
1 months 16 days ago
(26-Feb-2025)
4/10 (40%)
$19.82 (39.50%)
31
Buy
$65
$22.45 (52.76%)
$70
1 months 22 days ago
(20-Feb-2025)
0/2 (0%)
$15.49 (31.29%)
Buy
$65
$22.45 (52.76%)
$65
2 months 29 days ago
(13-Jan-2025)
10/13 (76.92%)
$6.49 (11.09%)
151
Buy
$72
$29.45 (69.21%)
$88
3 months 29 days ago
(13-Dec-2024)
2/3 (66.67%)
$10.75 (17.55%)
225
Buy
$75
$32.45 (76.26%)
$65
4 months 16 days ago
(26-Nov-2024)
37/45 (82.22%)
$14.9 (24.79%)
162
What Year was the first public recommendation made by Eric Criscuolo?
